RICHELDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.928
AS - Asia 8.292
EU - Europa 8.230
SA - Sud America 1.199
AF - Africa 195
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 21
Totale 37.898
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.684
GB - Regno Unito 2.773
SG - Singapore 2.622
CN - Cina 2.323
IT - Italia 1.638
HK - Hong Kong 1.005
BR - Brasile 915
VN - Vietnam 858
SE - Svezia 798
FI - Finlandia 600
DE - Germania 599
UA - Ucraina 504
FR - Francia 385
RU - Federazione Russa 348
TR - Turchia 332
KR - Corea 236
IN - India 215
BG - Bulgaria 172
CA - Canada 129
ID - Indonesia 121
NL - Olanda 96
BD - Bangladesh 90
AR - Argentina 87
MX - Messico 78
IQ - Iraq 75
ZA - Sudafrica 69
PK - Pakistan 63
JP - Giappone 50
EC - Ecuador 48
IE - Irlanda 43
PL - Polonia 38
ES - Italia 37
AE - Emirati Arabi Uniti 34
BE - Belgio 34
CO - Colombia 32
AT - Austria 30
UZ - Uzbekistan 30
MY - Malesia 27
CL - Cile 26
VE - Venezuela 25
IR - Iran 24
AU - Australia 22
PY - Paraguay 22
MA - Marocco 21
PE - Perù 21
NG - Nigeria 20
PH - Filippine 20
SA - Arabia Saudita 20
CH - Svizzera 17
TW - Taiwan 17
AL - Albania 16
AZ - Azerbaigian 16
JO - Giordania 16
TH - Thailandia 15
TN - Tunisia 15
CZ - Repubblica Ceca 14
DZ - Algeria 14
EU - Europa 13
KE - Kenya 13
EG - Egitto 12
LT - Lituania 11
NP - Nepal 11
OM - Oman 11
UY - Uruguay 10
BO - Bolivia 9
DK - Danimarca 8
SN - Senegal 8
HN - Honduras 7
IL - Israele 7
LB - Libano 7
PT - Portogallo 7
BH - Bahrain 6
ET - Etiopia 6
GR - Grecia 6
LV - Lettonia 6
PS - Palestinian Territory 6
RO - Romania 6
RS - Serbia 6
AM - Armenia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
FJ - Figi 5
HR - Croazia 5
KG - Kirghizistan 5
MD - Moldavia 5
NO - Norvegia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
CR - Costa Rica 4
JM - Giamaica 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
GE - Georgia 3
KZ - Kazakistan 3
AO - Angola 2
BN - Brunei Darussalam 2
BZ - Belize 2
Totale 37.843
Salva come PNG Salva come JPEG
Città #
Fairfield 2.178
Southend 2.014
Ashburn 1.702
Singapore 1.686
Santa Clara 1.635
Woodbridge 1.472
Houston 1.146
Hong Kong 974
Jacksonville 960
Chandler 921
Seattle 821
Hefei 804
Dearborn 752
Wilmington 725
Ann Arbor 696
Cambridge 691
San Jose 547
Nyköping 452
Beijing 443
Helsinki 426
London 410
Chicago 312
The Dalles 268
Los Angeles 266
Ho Chi Minh City 252
Hanoi 212
Council Bluffs 207
Seoul 197
San Diego 193
Modena 191
New York 191
Princeton 172
Sofia 165
Eugene 158
Lauterbourg 140
Salt Lake City 137
Izmir 125
Buffalo 116
Milan 111
Shanghai 91
Moscow 82
Jakarta 73
Dallas 71
Rome 68
São Paulo 66
Des Moines 64
Naples 63
Tampa 62
Columbus 60
Frankfurt am Main 53
Phoenix 53
Palermo 52
Redwood City 49
Bremen 46
Da Nang 43
Elk Grove Village 43
Haiphong 43
Orem 43
Dublin 40
Guangzhou 35
Boardman 34
Montreal 34
Brussels 32
Chennai 32
Sterling 32
Florence 31
Turin 31
Tokyo 30
Norwalk 29
Tashkent 29
San Francisco 28
Warsaw 28
Atlanta 27
Jersey City 27
Bari 26
Dong Ket 26
Mumbai 26
Lahore 25
Toronto 24
Munich 23
Rio de Janeiro 23
Baghdad 22
Bologna 22
Detroit 22
Kunming 22
Boston 21
Mexico City 21
Philadelphia 21
Amsterdam 20
Kent 20
Lancaster 20
Miami 20
Belo Horizonte 19
Brooklyn 19
Denver 19
Falls Church 19
San Mateo 19
Changsha 18
Long Branch 18
Quito 18
Totale 27.045
Salva come PNG Salva come JPEG
Nome #
Malattie infiltrative diffuse del polmone 1.154
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 789
Non-steroid agents for idiopathic pulmonary fibrosis 456
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 449
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 431
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 428
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 404
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 400
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 394
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 359
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 358
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias 357
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 355
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 354
Atypical lipomatous tumour (lipoma-like well-differentiated liposarcoma) arising in a pulmonary hamartoma and clinically presenting with pneumothorax 353
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 350
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management 337
Aortic pulse wave velocity measurement in systemic sclerosis patients. 336
A culture-proven case of community-acquired Legionella pneumonia apparently classified as nosocomial: diagnostic and public health implications 330
Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient 316
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 316
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts 315
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 313
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 312
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis 298
Management of idiopathic pulmonary fibrosis. 297
Rifabutin for treating pulmonary tuberculosis. 296
Emerging drugs for idiopathic pulmonary fibrosis. 296
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 294
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 294
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 291
A quantitative proteomic approach to identify significantly altered protein networks in the serum of patients with lymphangioleiomyomatosis (LAM) 287
Novel drug targets for idiopathic pulmonary fibrosis 286
Amyotrophic lateral sclerosis and sarcoidosis: a difficult differential diagnosis. 286
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 286
Pulmonary fibrosis and the many faces of UIP 285
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection 283
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 282
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis 282
Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis 281
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 280
Macrolides in the treatment of asthma and cystic fibrosis 278
An update on the diagnosis of tuberculosis infection 278
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 278
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 278
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 276
Early diagnosis of subclinical multi drug-resistant tuberculosis 268
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 268
Management of Idiopathic Pulmonary Fibrosis 267
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis 267
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 267
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 264
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials 263
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial 263
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. 260
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. 260
Sarcoidosis: challenging diagnostic aspects of an old disease. 256
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis 255
Smoking-related interstitial lung disease 251
Blood tests for diagnosis of tuberculosis - Reply 250
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 247
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy 244
Prevalence and prognosis of unclassifiable interstitial lung disease 243
Unexpected identification of bilateral masses in an asymptomatic heavy smoker. 242
Identification Of Potential Candidate Biomarkers In Lymphangioleiomyomatosis Using ITRAQ Proteomic Technology 238
The big clinical trials in idiopathic pulmonary fibrosis. 238
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 236
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 234
Inappropriatezza prescrittiva dell'ossigenoterapia domiciliare a lungo termine 230
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. 230
Challenges in idiopathic interstitial lung disease 228
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis 226
The complex interrelationships between chronic lung and liver disease: a review. 224
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 224
L'infezione tubercolare nel bambino: il contributo dei nuovi test immunologici 223
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 222
Macrolides for chronic asthma. 221
MOLECULAR DIAGNOSIS OF TUBERCULOSIS 221
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 220
Tubercolosi 220
Immunomodulatory agents for idiopathic pulmonary fibrosis. 219
ANTIBODY REPERTOIRE AGAINST THE A60 ANTIGEN COMPLEX DURING THE COURSE OF PULMONARY TUBERCULOSIS 218
Levels Of Fibulin-1 In The Lung And Serum Are Increased In Fibrotic Interstitial Lung Disease 216
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 214
HLA-DPB1 Glutamate 69: a genetic marker of beryllium disease 213
Tuberculosis infection in foreign-born children: a screening survey based on skin and blood testing. 212
Role of the quantiferon-TB test in ruling out pleural tuberculosis: a multi-centre study. 212
Mycobacterium tuberculosis induces CCL18 expression in human macrophages 210
Analysis of sputum in COPD 209
Immunogenetic basis of environmental lung disease: lessons from the berylliosis model 206
Interaction of genetic and exposure factors in the prevalence of berylliosis 206
Interferon gamma assays for tuberculosis 204
Genetic testing in diffuse parenchymal lung disease 203
The role of biomarkers in low respiratory tract infections. 202
Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosis 201
New tools for a better diagnosis of latent tuberculosis infection 200
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis. 198
A genetic marker for chronic beryllium disease. 198
Tuberculosis diagnostic tests: Sensitivity, specificity, and comparing apples with apples 197
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis 196
Totale 28.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.824
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021859 0 0 0 0 0 0 0 0 0 417 243 199
2021/20222.903 86 488 275 221 59 87 200 108 293 208 525 353
2022/20232.694 324 274 169 241 317 402 47 292 331 81 116 100
2023/20242.023 62 129 124 173 372 244 245 244 67 47 128 188
2024/20255.889 212 90 84 417 1.236 847 389 367 631 357 585 674
2025/202610.589 676 489 1.084 1.283 1.747 1.035 1.538 649 1.153 935 0 0
Totale 38.098